Know Cancer

or
forgot password

Genetic Epidemiology of Lymphoproliferative Disorders


N/A
18 Years
N/A
Open (Enrolling)
Both
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Monoclonal B-Cell Lymphocytosis, Multiple Myeloma

Thank you

Trial Information

Genetic Epidemiology of Lymphoproliferative Disorders

Inclusion Criteria


At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.

Type of Study:

Observational

Study Design:

Observational Model: Family-Based, Time Perspective: Prospective

Outcome Measure:

Risk of blood or lymphoma

Outcome Time Frame:

Ongoing

Safety Issue:

No

Principal Investigator

Susan Slager, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

489-04

NCT ID:

NCT00626496

Start Date:

April 2004

Completion Date:

Related Keywords:

  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, B-Cell
  • Monoclonal B-Cell Lymphocytosis
  • Multiple Myeloma
  • Leukemia
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Lymphoid
  • Lymphocytosis
  • Lymphoma
  • Lymphoma, Non-Hodgkin
  • Lymphoproliferative Disorders
  • Multiple Myeloma
  • Neoplasms, Plasma Cell
  • Lymphoma, B-Cell

Name

Location

Mayo ClinicRochester, Minnesota  55905